Metraipolis › archive › dc_838dfdbf38f4

The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists — Europe PMC PMID:41294832

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41294832
DOI
10.3390/cells14221779
License (as archived)
solo-consultazione
Archived
2026-11-08T15:37:03.105Z
SHA-256 of the archived text
bd7298cb389fa35ccf66f23ed3012a466481451ec816a73c6ee2e4428106f24a
Stable URL of this page
https://metraipolis.com/documento/dc_838dfdbf38f4

How to cite

The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists — Europe PMC PMID:41294832 — Europe PMC (en), https://europepmc.org/article/MED/41294832 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_838dfdbf38f4 (Metraipolis archive dc_838dfdbf38f4, sha256 bd7298cb389fa35ccf66f23ed3012a466481451ec816a73c6ee2e4428106f24a)
BibTeX
@misc{dc838dfdbf38f4,
  title = {The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists — Europe PMC PMID:41294832},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41294832},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_838dfdbf38f4; sha256 bd7298cb389fa35ccf66f23ed3012a466481451ec816a73c6ee2e4428106f24a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41294832. Agents can read the archived copy with the MCP tool read_document.